Crohns Stem Cell Therapy - Premier Stem Cell Institute
Stem Cell Therapy,regenerative therapy,stem cell treatment, joint treatment,back treatment,spine therapy, joint therapy
15588
page-template,page-template-full_width,page-template-full_width-php,page,page-id-15588,page-child,parent-pageid-15576,ajax_updown_fade,page_not_loaded,,qode-child-theme-ver-1.0.0,qode-theme-ver-7.4,wpb-js-composer js-comp-ver-5.1,vc_responsive
 

Crohn’s

Crohn’s disease is a chronic inflammatory condition of the gastrointestinal (GI) tract. Crohn’s most commonly affects the end of the small bowel (the ileum) and the beginning of the colon, but it may affect any part of the gastrointestinal GI tract.

According to the Crohn’s & Colitis Foundation, up to 700,000 Americans have Crohn’s – a chronic inflammatory disease that arises when the immune system mistakenly attacks the lining of the digestive tract. It causes abdominal cramps, diarrhea, constipation, and rectal bleeding.

For patients suffering with these symptoms, intravenous infusions of mesenchymal stem cells can potentially control damage from an overactive immune system, restore function to damaged tissues, decrease cell death, and increase blood flow.

Intravenous mesenchymal stem cell therapy may also replenish stem cell supply to the bowel and may aid in the healing of fistulas, which are a common but serious complication of Crohn’s.

Stem cell therapy is in the experimental stage, and it’s important to have the best available information to make the best decisions related to this complex issue. Stem cell therapy is one of many measures of care and is by no means currently considered a cure.

Request a Consultation